nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—CYP2D6—epilepsy syndrome	0.545	1	CbGaD
Carteolol—Palpitations—Fosphenytoin—epilepsy syndrome	0.000656	0.00197	CcSEcCtD
Carteolol—Loss of consciousness—Fosphenytoin—epilepsy syndrome	0.000653	0.00196	CcSEcCtD
Carteolol—Diplopia—Gabapentin—epilepsy syndrome	0.000652	0.00196	CcSEcCtD
Carteolol—Oedema—Propofol—epilepsy syndrome	0.00065	0.00195	CcSEcCtD
Carteolol—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000647	0.00194	CcSEcCtD
Carteolol—Shock—Propofol—epilepsy syndrome	0.00064	0.00192	CcSEcCtD
Carteolol—Syncope—Diazepam—epilepsy syndrome	0.000639	0.00192	CcSEcCtD
Carteolol—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000635	0.0019	CcSEcCtD
Carteolol—Arrhythmia—Carbamazepine—epilepsy syndrome	0.000633	0.0019	CcSEcCtD
Carteolol—Dysgeusia—Phenytoin—epilepsy syndrome	0.000633	0.0019	CcSEcCtD
Carteolol—Diabetes mellitus—Topiramate—epilepsy syndrome	0.000631	0.00189	CcSEcCtD
Carteolol—Palpitations—Diazepam—epilepsy syndrome	0.00063	0.00189	CcSEcCtD
Carteolol—Dysgeusia—Oxcarbazepine—epilepsy syndrome	0.00063	0.00189	CcSEcCtD
Carteolol—Loss of consciousness—Diazepam—epilepsy syndrome	0.000626	0.00188	CcSEcCtD
Carteolol—Shock—Midazolam—epilepsy syndrome	0.000626	0.00188	CcSEcCtD
Carteolol—Headache—Trimethadione—epilepsy syndrome	0.000621	0.00186	CcSEcCtD
Carteolol—Asthenia—Rufinamide—epilepsy syndrome	0.000618	0.00185	CcSEcCtD
Carteolol—Vision blurred—Clonazepam—epilepsy syndrome	0.000613	0.00184	CcSEcCtD
Carteolol—Palpitations—Felbamate—epilepsy syndrome	0.00061	0.00183	CcSEcCtD
Carteolol—Hypotension—Propofol—epilepsy syndrome	0.000607	0.00182	CcSEcCtD
Carteolol—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.000606	0.00182	CcSEcCtD
Carteolol—Syncope—Zonisamide—epilepsy syndrome	0.000606	0.00182	CcSEcCtD
Carteolol—Depression—Valproic Acid—epilepsy syndrome	0.000605	0.00181	CcSEcCtD
Carteolol—Dysgeusia—Carbamazepine—epilepsy syndrome	0.000604	0.00181	CcSEcCtD
Carteolol—Palpitations—Zonisamide—epilepsy syndrome	0.000597	0.00179	CcSEcCtD
Carteolol—Shock—Fosphenytoin—epilepsy syndrome	0.000596	0.00179	CcSEcCtD
Carteolol—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000596	0.00179	CcSEcCtD
Carteolol—Hypotension—Midazolam—epilepsy syndrome	0.000594	0.00178	CcSEcCtD
Carteolol—Loss of consciousness—Zonisamide—epilepsy syndrome	0.000593	0.00178	CcSEcCtD
Carteolol—Oedema—Vigabatrin—epilepsy syndrome	0.000591	0.00177	CcSEcCtD
Carteolol—Conjunctivitis—Valproic Acid—epilepsy syndrome	0.000589	0.00177	CcSEcCtD
Carteolol—Nausea—Trimethadione—epilepsy syndrome	0.000589	0.00177	CcSEcCtD
Carteolol—Insomnia—Propofol—epilepsy syndrome	0.000588	0.00176	CcSEcCtD
Carteolol—Dysgeusia—Lamotrigine—epilepsy syndrome	0.000584	0.00175	CcSEcCtD
Carteolol—Vision blurred—Carbamazepine—epilepsy syndrome	0.000582	0.00174	CcSEcCtD
Carteolol—Asthenia—Lacosamide—epilepsy syndrome	0.00058	0.00174	CcSEcCtD
Carteolol—Dizziness—Phenobarbital—epilepsy syndrome	0.00058	0.00174	CcSEcCtD
Carteolol—Syncope—Phenytoin—epilepsy syndrome	0.00058	0.00174	CcSEcCtD
Carteolol—Dyspnoea—Propofol—epilepsy syndrome	0.00058	0.00174	CcSEcCtD
Carteolol—Visual disturbance—Topiramate—epilepsy syndrome	0.000579	0.00174	CcSEcCtD
Carteolol—Syncope—Oxcarbazepine—epilepsy syndrome	0.000577	0.00173	CcSEcCtD
Carteolol—Palpitations—Clonazepam—epilepsy syndrome	0.000575	0.00172	CcSEcCtD
Carteolol—Shock—Diazepam—epilepsy syndrome	0.000572	0.00172	CcSEcCtD
Carteolol—Palpitations—Phenytoin—epilepsy syndrome	0.000571	0.00171	CcSEcCtD
Carteolol—Dizziness—Rufinamide—epilepsy syndrome	0.00057	0.00171	CcSEcCtD
Carteolol—Sinusitis—Valproic Acid—epilepsy syndrome	0.000569	0.00171	CcSEcCtD
Carteolol—Palpitations—Oxcarbazepine—epilepsy syndrome	0.000568	0.0017	CcSEcCtD
Carteolol—Loss of consciousness—Phenytoin—epilepsy syndrome	0.000568	0.0017	CcSEcCtD
Carteolol—Insomnia—Levetiracetam—epilepsy syndrome	0.000568	0.0017	CcSEcCtD
Carteolol—Dyspnoea—Midazolam—epilepsy syndrome	0.000567	0.0017	CcSEcCtD
Carteolol—Hypotension—Fosphenytoin—epilepsy syndrome	0.000566	0.0017	CcSEcCtD
Carteolol—Loss of consciousness—Oxcarbazepine—epilepsy syndrome	0.000565	0.00169	CcSEcCtD
Carteolol—Asthenia—Clobazam—epilepsy syndrome	0.000563	0.00169	CcSEcCtD
Carteolol—Oedema—Felbamate—epilepsy syndrome	0.000563	0.00169	CcSEcCtD
Carteolol—Hypoglycaemia—Topiramate—epilepsy syndrome	0.000562	0.00169	CcSEcCtD
Carteolol—Vision blurred—Lamotrigine—epilepsy syndrome	0.000562	0.00169	CcSEcCtD
Carteolol—Bronchospasm—Gabapentin—epilepsy syndrome	0.000555	0.00166	CcSEcCtD
Carteolol—Bradycardia—Valproic Acid—epilepsy syndrome	0.000554	0.00166	CcSEcCtD
Carteolol—Syncope—Carbamazepine—epilepsy syndrome	0.000553	0.00166	CcSEcCtD
Carteolol—Oedema—Zonisamide—epilepsy syndrome	0.000551	0.00165	CcSEcCtD
Carteolol—Headache—Phenobarbital—epilepsy syndrome	0.00055	0.00165	CcSEcCtD
Carteolol—Diplopia—Topiramate—epilepsy syndrome	0.000549	0.00165	CcSEcCtD
Carteolol—Insomnia—Fosphenytoin—epilepsy syndrome	0.000548	0.00164	CcSEcCtD
Carteolol—Depression—Pregabalin—epilepsy syndrome	0.000547	0.00164	CcSEcCtD
Carteolol—Hypotension—Diazepam—epilepsy syndrome	0.000544	0.00163	CcSEcCtD
Carteolol—Loss of consciousness—Carbamazepine—epilepsy syndrome	0.000542	0.00163	CcSEcCtD
Carteolol—Shock—Zonisamide—epilepsy syndrome	0.000542	0.00163	CcSEcCtD
Carteolol—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.00054	0.00162	CcSEcCtD
Carteolol—Headache—Rufinamide—epilepsy syndrome	0.00054	0.00162	CcSEcCtD
Carteolol—Dizziness—Lacosamide—epilepsy syndrome	0.000535	0.0016	CcSEcCtD
Carteolol—Syncope—Lamotrigine—epilepsy syndrome	0.000535	0.0016	CcSEcCtD
Carteolol—Insomnia—Vigabatrin—epilepsy syndrome	0.000534	0.0016	CcSEcCtD
Carteolol—Conjunctivitis—Pregabalin—epilepsy syndrome	0.000533	0.0016	CcSEcCtD
Carteolol—Oedema—Clonazepam—epilepsy syndrome	0.000531	0.00159	CcSEcCtD
Carteolol—Palpitations—Lamotrigine—epilepsy syndrome	0.000527	0.00158	CcSEcCtD
Carteolol—Insomnia—Diazepam—epilepsy syndrome	0.000526	0.00158	CcSEcCtD
Carteolol—Hypotension—Felbamate—epilepsy syndrome	0.000526	0.00158	CcSEcCtD
Carteolol—Visual impairment—Valproic Acid—epilepsy syndrome	0.000525	0.00157	CcSEcCtD
Carteolol—Loss of consciousness—Lamotrigine—epilepsy syndrome	0.000524	0.00157	CcSEcCtD
Carteolol—Nausea—Phenobarbital—epilepsy syndrome	0.000521	0.00156	CcSEcCtD
Carteolol—Dizziness—Clobazam—epilepsy syndrome	0.000519	0.00156	CcSEcCtD
Carteolol—Shock—Phenytoin—epilepsy syndrome	0.000519	0.00156	CcSEcCtD
Carteolol—Dyspnoea—Diazepam—epilepsy syndrome	0.000519	0.00156	CcSEcCtD
Carteolol—Shock—Oxcarbazepine—epilepsy syndrome	0.000516	0.00155	CcSEcCtD
Carteolol—Hypotension—Zonisamide—epilepsy syndrome	0.000515	0.00154	CcSEcCtD
Carteolol—Sinusitis—Pregabalin—epilepsy syndrome	0.000514	0.00154	CcSEcCtD
Carteolol—Nausea—Rufinamide—epilepsy syndrome	0.000512	0.00153	CcSEcCtD
Carteolol—Insomnia—Felbamate—epilepsy syndrome	0.000509	0.00153	CcSEcCtD
Carteolol—Headache—Lacosamide—epilepsy syndrome	0.000507	0.00152	CcSEcCtD
Carteolol—Oedema—Carbamazepine—epilepsy syndrome	0.000504	0.00151	CcSEcCtD
Carteolol—Asthenia—Acetazolamide—epilepsy syndrome	0.000502	0.00151	CcSEcCtD
Carteolol—Dyspnoea—Felbamate—epilepsy syndrome	0.000502	0.00151	CcSEcCtD
Carteolol—Depression—Gabapentin—epilepsy syndrome	0.000501	0.0015	CcSEcCtD
Carteolol—Bradycardia—Pregabalin—epilepsy syndrome	0.000501	0.0015	CcSEcCtD
Carteolol—Insomnia—Zonisamide—epilepsy syndrome	0.000498	0.00149	CcSEcCtD
Carteolol—Hypotension—Clonazepam—epilepsy syndrome	0.000496	0.00149	CcSEcCtD
Carteolol—Shock—Carbamazepine—epilepsy syndrome	0.000495	0.00149	CcSEcCtD
Carteolol—Hypotension—Phenytoin—epilepsy syndrome	0.000493	0.00148	CcSEcCtD
Carteolol—Headache—Clobazam—epilepsy syndrome	0.000492	0.00148	CcSEcCtD
Carteolol—Dyspnoea—Zonisamide—epilepsy syndrome	0.000491	0.00147	CcSEcCtD
Carteolol—Hypotension—Oxcarbazepine—epilepsy syndrome	0.00049	0.00147	CcSEcCtD
Carteolol—Conjunctivitis—Gabapentin—epilepsy syndrome	0.000489	0.00147	CcSEcCtD
Carteolol—Oedema—Lamotrigine—epilepsy syndrome	0.000487	0.00146	CcSEcCtD
Carteolol—Arrhythmia—Valproic Acid—epilepsy syndrome	0.000486	0.00146	CcSEcCtD
Carteolol—Nausea—Lacosamide—epilepsy syndrome	0.000481	0.00144	CcSEcCtD
Carteolol—Insomnia—Clonazepam—epilepsy syndrome	0.00048	0.00144	CcSEcCtD
Carteolol—Shock—Lamotrigine—epilepsy syndrome	0.000479	0.00144	CcSEcCtD
Carteolol—Insomnia—Phenytoin—epilepsy syndrome	0.000477	0.00143	CcSEcCtD
Carteolol—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000475	0.00142	CcSEcCtD
Carteolol—Visual impairment—Pregabalin—epilepsy syndrome	0.000474	0.00142	CcSEcCtD
Carteolol—Dyspnoea—Clonazepam—epilepsy syndrome	0.000474	0.00142	CcSEcCtD
Carteolol—Sinusitis—Gabapentin—epilepsy syndrome	0.000472	0.00141	CcSEcCtD
Carteolol—Hypotension—Carbamazepine—epilepsy syndrome	0.000471	0.00141	CcSEcCtD
Carteolol—Dyspnoea—Phenytoin—epilepsy syndrome	0.00047	0.00141	CcSEcCtD
Carteolol—Hypersensitivity—Midazolam—epilepsy syndrome	0.000469	0.00141	CcSEcCtD
Carteolol—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000468	0.0014	CcSEcCtD
Carteolol—Nausea—Clobazam—epilepsy syndrome	0.000466	0.0014	CcSEcCtD
Carteolol—Asthenia—Propofol—epilepsy syndrome	0.000466	0.0014	CcSEcCtD
Carteolol—Dysgeusia—Valproic Acid—epilepsy syndrome	0.000464	0.00139	CcSEcCtD
Carteolol—Dizziness—Acetazolamide—epilepsy syndrome	0.000463	0.00139	CcSEcCtD
Carteolol—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000463	0.00139	CcSEcCtD
Carteolol—Bradycardia—Gabapentin—epilepsy syndrome	0.000459	0.00138	CcSEcCtD
Carteolol—Asthenia—Midazolam—epilepsy syndrome	0.000456	0.00137	CcSEcCtD
Carteolol—Insomnia—Carbamazepine—epilepsy syndrome	0.000455	0.00137	CcSEcCtD
Carteolol—Asthenia—Levetiracetam—epilepsy syndrome	0.000451	0.00135	CcSEcCtD
Carteolol—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000449	0.00135	CcSEcCtD
Carteolol—Vision blurred—Valproic Acid—epilepsy syndrome	0.000447	0.00134	CcSEcCtD
Carteolol—Insomnia—Lamotrigine—epilepsy syndrome	0.00044	0.00132	CcSEcCtD
Carteolol—Arrhythmia—Pregabalin—epilepsy syndrome	0.00044	0.00132	CcSEcCtD
Carteolol—Headache—Acetazolamide—epilepsy syndrome	0.000438	0.00131	CcSEcCtD
Carteolol—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000435	0.00131	CcSEcCtD
Carteolol—Asthenia—Fosphenytoin—epilepsy syndrome	0.000435	0.0013	CcSEcCtD
Carteolol—Visual impairment—Gabapentin—epilepsy syndrome	0.000435	0.0013	CcSEcCtD
Carteolol—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000434	0.0013	CcSEcCtD
Carteolol—Dizziness—Propofol—epilepsy syndrome	0.00043	0.00129	CcSEcCtD
Carteolol—Hypersensitivity—Diazepam—epilepsy syndrome	0.000429	0.00129	CcSEcCtD
Carteolol—Asthenia—Vigabatrin—epilepsy syndrome	0.000424	0.00127	CcSEcCtD
Carteolol—Depression—Topiramate—epilepsy syndrome	0.000422	0.00126	CcSEcCtD
Carteolol—Dizziness—Midazolam—epilepsy syndrome	0.000421	0.00126	CcSEcCtD
Carteolol—Dysgeusia—Pregabalin—epilepsy syndrome	0.00042	0.00126	CcSEcCtD
Carteolol—Palpitations—Valproic Acid—epilepsy syndrome	0.000419	0.00126	CcSEcCtD
Carteolol—Asthenia—Diazepam—epilepsy syndrome	0.000417	0.00125	CcSEcCtD
Carteolol—Nausea—Acetazolamide—epilepsy syndrome	0.000416	0.00125	CcSEcCtD
Carteolol—Dizziness—Levetiracetam—epilepsy syndrome	0.000415	0.00125	CcSEcCtD
Carteolol—Conjunctivitis—Topiramate—epilepsy syndrome	0.000411	0.00123	CcSEcCtD
Carteolol—Headache—Propofol—epilepsy syndrome	0.000407	0.00122	CcSEcCtD
Carteolol—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000406	0.00122	CcSEcCtD
Carteolol—Asthenia—Felbamate—epilepsy syndrome	0.000404	0.00121	CcSEcCtD
Carteolol—Vision blurred—Pregabalin—epilepsy syndrome	0.000404	0.00121	CcSEcCtD
Carteolol—Dizziness—Fosphenytoin—epilepsy syndrome	0.000401	0.0012	CcSEcCtD
Carteolol—Headache—Midazolam—epilepsy syndrome	0.000398	0.00119	CcSEcCtD
Carteolol—Sinusitis—Topiramate—epilepsy syndrome	0.000397	0.00119	CcSEcCtD
Carteolol—Asthenia—Zonisamide—epilepsy syndrome	0.000395	0.00119	CcSEcCtD
Carteolol—Headache—Levetiracetam—epilepsy syndrome	0.000393	0.00118	CcSEcCtD
Carteolol—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000391	0.00117	CcSEcCtD
Carteolol—Dizziness—Vigabatrin—epilepsy syndrome	0.000391	0.00117	CcSEcCtD
Carteolol—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000389	0.00117	CcSEcCtD
Carteolol—Oedema—Valproic Acid—epilepsy syndrome	0.000387	0.00116	CcSEcCtD
Carteolol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000387	0.00116	CcSEcCtD
Carteolol—Bradycardia—Topiramate—epilepsy syndrome	0.000387	0.00116	CcSEcCtD
Carteolol—Nausea—Propofol—epilepsy syndrome	0.000386	0.00116	CcSEcCtD
Carteolol—Dysgeusia—Gabapentin—epilepsy syndrome	0.000385	0.00115	CcSEcCtD
Carteolol—Dizziness—Diazepam—epilepsy syndrome	0.000385	0.00115	CcSEcCtD
Carteolol—Syncope—Pregabalin—epilepsy syndrome	0.000384	0.00115	CcSEcCtD
Carteolol—Asthenia—Clonazepam—epilepsy syndrome	0.000381	0.00114	CcSEcCtD
Carteolol—Headache—Fosphenytoin—epilepsy syndrome	0.00038	0.00114	CcSEcCtD
Carteolol—Palpitations—Pregabalin—epilepsy syndrome	0.000379	0.00114	CcSEcCtD
Carteolol—Asthenia—Phenytoin—epilepsy syndrome	0.000379	0.00114	CcSEcCtD
Carteolol—Nausea—Midazolam—epilepsy syndrome	0.000378	0.00113	CcSEcCtD
Carteolol—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000377	0.00113	CcSEcCtD
Carteolol—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000377	0.00113	CcSEcCtD
Carteolol—Nausea—Levetiracetam—epilepsy syndrome	0.000373	0.00112	CcSEcCtD
Carteolol—Dizziness—Felbamate—epilepsy syndrome	0.000372	0.00112	CcSEcCtD
Carteolol—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000371	0.00111	CcSEcCtD
Carteolol—Vision blurred—Gabapentin—epilepsy syndrome	0.00037	0.00111	CcSEcCtD
Carteolol—Headache—Vigabatrin—epilepsy syndrome	0.00037	0.00111	CcSEcCtD
Carteolol—Visual impairment—Topiramate—epilepsy syndrome	0.000366	0.0011	CcSEcCtD
Carteolol—Dizziness—Zonisamide—epilepsy syndrome	0.000364	0.00109	CcSEcCtD
Carteolol—Headache—Diazepam—epilepsy syndrome	0.000364	0.00109	CcSEcCtD
Carteolol—Hypotension—Valproic Acid—epilepsy syndrome	0.000361	0.00108	CcSEcCtD
Carteolol—Asthenia—Carbamazepine—epilepsy syndrome	0.000361	0.00108	CcSEcCtD
Carteolol—Nausea—Fosphenytoin—epilepsy syndrome	0.00036	0.00108	CcSEcCtD
Carteolol—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000359	0.00108	CcSEcCtD
Carteolol—Headache—Felbamate—epilepsy syndrome	0.000353	0.00106	CcSEcCtD
Carteolol—Syncope—Gabapentin—epilepsy syndrome	0.000352	0.00106	CcSEcCtD
Carteolol—Dizziness—Clonazepam—epilepsy syndrome	0.000351	0.00105	CcSEcCtD
Carteolol—Nausea—Vigabatrin—epilepsy syndrome	0.000351	0.00105	CcSEcCtD
Carteolol—Insomnia—Valproic Acid—epilepsy syndrome	0.00035	0.00105	CcSEcCtD
Carteolol—Oedema—Pregabalin—epilepsy syndrome	0.00035	0.00105	CcSEcCtD
Carteolol—Asthenia—Lamotrigine—epilepsy syndrome	0.000349	0.00105	CcSEcCtD
Carteolol—Dizziness—Phenytoin—epilepsy syndrome	0.000349	0.00105	CcSEcCtD
Carteolol—Palpitations—Gabapentin—epilepsy syndrome	0.000347	0.00104	CcSEcCtD
Carteolol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000347	0.00104	CcSEcCtD
Carteolol—Nausea—Diazepam—epilepsy syndrome	0.000346	0.00104	CcSEcCtD
Carteolol—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000345	0.00104	CcSEcCtD
Carteolol—Headache—Zonisamide—epilepsy syndrome	0.000345	0.00104	CcSEcCtD
Carteolol—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000345	0.00103	CcSEcCtD
Carteolol—Shock—Pregabalin—epilepsy syndrome	0.000344	0.00103	CcSEcCtD
Carteolol—Nausea—Felbamate—epilepsy syndrome	0.000334	0.001	CcSEcCtD
Carteolol—Dizziness—Carbamazepine—epilepsy syndrome	0.000333	0.000999	CcSEcCtD
Carteolol—Headache—Clonazepam—epilepsy syndrome	0.000333	0.000998	CcSEcCtD
Carteolol—Headache—Phenytoin—epilepsy syndrome	0.000331	0.000991	CcSEcCtD
Carteolol—Headache—Oxcarbazepine—epilepsy syndrome	0.000329	0.000986	CcSEcCtD
Carteolol—Nausea—Zonisamide—epilepsy syndrome	0.000327	0.000982	CcSEcCtD
Carteolol—Hypotension—Pregabalin—epilepsy syndrome	0.000327	0.00098	CcSEcCtD
Carteolol—Dysgeusia—Topiramate—epilepsy syndrome	0.000324	0.000971	CcSEcCtD
Carteolol—Dizziness—Lamotrigine—epilepsy syndrome	0.000322	0.000965	CcSEcCtD
Carteolol—Oedema—Gabapentin—epilepsy syndrome	0.000321	0.000961	CcSEcCtD
Carteolol—Insomnia—Pregabalin—epilepsy syndrome	0.000316	0.000948	CcSEcCtD
Carteolol—Nausea—Clonazepam—epilepsy syndrome	0.000315	0.000946	CcSEcCtD
Carteolol—Headache—Carbamazepine—epilepsy syndrome	0.000315	0.000946	CcSEcCtD
Carteolol—Shock—Gabapentin—epilepsy syndrome	0.000315	0.000946	CcSEcCtD
Carteolol—Nausea—Phenytoin—epilepsy syndrome	0.000313	0.00094	CcSEcCtD
Carteolol—Dyspnoea—Pregabalin—epilepsy syndrome	0.000312	0.000935	CcSEcCtD
Carteolol—Nausea—Oxcarbazepine—epilepsy syndrome	0.000312	0.000935	CcSEcCtD
Carteolol—Vision blurred—Topiramate—epilepsy syndrome	0.000311	0.000934	CcSEcCtD
Carteolol—Headache—Lamotrigine—epilepsy syndrome	0.000305	0.000914	CcSEcCtD
Carteolol—Nadolol—ABCB1—epilepsy syndrome	0.0003	0.298	CrCbGaD
Carteolol—Hypotension—Gabapentin—epilepsy syndrome	0.0003	0.000898	CcSEcCtD
Carteolol—Nausea—Carbamazepine—epilepsy syndrome	0.000299	0.000897	CcSEcCtD
Carteolol—Syncope—Topiramate—epilepsy syndrome	0.000296	0.000889	CcSEcCtD
Carteolol—Palpitations—Topiramate—epilepsy syndrome	0.000292	0.000876	CcSEcCtD
Carteolol—Loss of consciousness—Topiramate—epilepsy syndrome	0.00029	0.000871	CcSEcCtD
Carteolol—Insomnia—Gabapentin—epilepsy syndrome	0.00029	0.00087	CcSEcCtD
Carteolol—Nausea—Lamotrigine—epilepsy syndrome	0.000289	0.000867	CcSEcCtD
Carteolol—Dyspnoea—Gabapentin—epilepsy syndrome	0.000286	0.000857	CcSEcCtD
Carteolol—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000285	0.000855	CcSEcCtD
Carteolol—Asthenia—Valproic Acid—epilepsy syndrome	0.000277	0.000832	CcSEcCtD
Carteolol—Oedema—Topiramate—epilepsy syndrome	0.00027	0.000809	CcSEcCtD
Carteolol—Shock—Topiramate—epilepsy syndrome	0.000265	0.000796	CcSEcCtD
Carteolol—Pindolol—CYP2D6—epilepsy syndrome	0.000264	0.263	CrCbGaD
Carteolol—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000258	0.000773	CcSEcCtD
Carteolol—Dizziness—Valproic Acid—epilepsy syndrome	0.000256	0.000767	CcSEcCtD
Carteolol—Hypotension—Topiramate—epilepsy syndrome	0.000252	0.000756	CcSEcCtD
Carteolol—Asthenia—Pregabalin—epilepsy syndrome	0.000251	0.000752	CcSEcCtD
Carteolol—Insomnia—Topiramate—epilepsy syndrome	0.000244	0.000732	CcSEcCtD
Carteolol—Headache—Valproic Acid—epilepsy syndrome	0.000242	0.000727	CcSEcCtD
Carteolol—Dyspnoea—Topiramate—epilepsy syndrome	0.00024	0.000721	CcSEcCtD
Carteolol—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000236	0.000708	CcSEcCtD
Carteolol—Dizziness—Pregabalin—epilepsy syndrome	0.000231	0.000693	CcSEcCtD
Carteolol—Asthenia—Gabapentin—epilepsy syndrome	0.00023	0.00069	CcSEcCtD
Carteolol—Nausea—Valproic Acid—epilepsy syndrome	0.00023	0.000689	CcSEcCtD
Carteolol—Headache—Pregabalin—epilepsy syndrome	0.000219	0.000657	CcSEcCtD
Carteolol—Dizziness—Gabapentin—epilepsy syndrome	0.000212	0.000636	CcSEcCtD
Carteolol—Nausea—Pregabalin—epilepsy syndrome	0.000208	0.000623	CcSEcCtD
Carteolol—Headache—Gabapentin—epilepsy syndrome	0.000201	0.000602	CcSEcCtD
Carteolol—Hypersensitivity—Topiramate—epilepsy syndrome	0.000199	0.000596	CcSEcCtD
Carteolol—Propranolol—CYP2C19—epilepsy syndrome	0.000194	0.193	CrCbGaD
Carteolol—Asthenia—Topiramate—epilepsy syndrome	0.000194	0.00058	CcSEcCtD
Carteolol—Nausea—Gabapentin—epilepsy syndrome	0.00019	0.000571	CcSEcCtD
Carteolol—Dizziness—Topiramate—epilepsy syndrome	0.000178	0.000535	CcSEcCtD
Carteolol—Headache—Topiramate—epilepsy syndrome	0.000169	0.000507	CcSEcCtD
Carteolol—Nausea—Topiramate—epilepsy syndrome	0.00016	0.00048	CcSEcCtD
Carteolol—Propranolol—CYP2D6—epilepsy syndrome	0.000144	0.143	CrCbGaD
Carteolol—Propranolol—ABCB1—epilepsy syndrome	0.000103	0.102	CrCbGaD
Carteolol—ADRB2—Signaling Pathways—GRM8—epilepsy syndrome	4.99e-05	0.000415	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PGF—epilepsy syndrome	4.99e-05	0.000415	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ADRA2A—epilepsy syndrome	4.98e-05	0.000414	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCR2—epilepsy syndrome	4.98e-05	0.000414	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—SST—epilepsy syndrome	4.98e-05	0.000414	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—HTR7—epilepsy syndrome	4.94e-05	0.00041	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—COX3—epilepsy syndrome	4.89e-05	0.000407	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CCL2—epilepsy syndrome	4.89e-05	0.000406	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—POMC—epilepsy syndrome	4.89e-05	0.000406	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ADRA2A—epilepsy syndrome	4.87e-05	0.000405	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—OPRD1—epilepsy syndrome	4.87e-05	0.000404	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GNAO1—epilepsy syndrome	4.87e-05	0.000404	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT3—epilepsy syndrome	4.81e-05	0.0004	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CXCL12—epilepsy syndrome	4.79e-05	0.000398	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—BDKRB2—epilepsy syndrome	4.79e-05	0.000398	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CCL2—epilepsy syndrome	4.78e-05	0.000397	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—OPRD1—epilepsy syndrome	4.76e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GNAO1—epilepsy syndrome	4.76e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT3—epilepsy syndrome	4.71e-05	0.000391	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CNR1—epilepsy syndrome	4.7e-05	0.00039	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—BDKRB2—epilepsy syndrome	4.68e-05	0.000389	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CXCL12—epilepsy syndrome	4.68e-05	0.000389	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PLCB1—epilepsy syndrome	4.68e-05	0.000389	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CHRM1—epilepsy syndrome	4.67e-05	0.000388	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GRM1—epilepsy syndrome	4.67e-05	0.000388	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PDYN—epilepsy syndrome	4.67e-05	0.000388	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCR7—epilepsy syndrome	4.67e-05	0.000388	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	4.64e-05	0.000385	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PFKL—epilepsy syndrome	4.64e-05	0.000385	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	4.64e-05	0.000385	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	4.64e-05	0.000385	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	4.64e-05	0.000385	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CNR1—epilepsy syndrome	4.6e-05	0.000382	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HTR7—epilepsy syndrome	4.58e-05	0.000381	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PLCB1—epilepsy syndrome	4.58e-05	0.00038	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCR7—epilepsy syndrome	4.57e-05	0.000379	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CHRM1—epilepsy syndrome	4.57e-05	0.000379	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PDYN—epilepsy syndrome	4.57e-05	0.000379	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GRM1—epilepsy syndrome	4.57e-05	0.000379	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HTR7—epilepsy syndrome	4.48e-05	0.000372	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HBEGF—epilepsy syndrome	4.45e-05	0.00037	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CDC42—epilepsy syndrome	4.39e-05	0.000365	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GFAP—epilepsy syndrome	4.39e-05	0.000365	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GAL—epilepsy syndrome	4.39e-05	0.000365	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT3—epilepsy syndrome	4.37e-05	0.000363	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HBEGF—epilepsy syndrome	4.35e-05	0.000362	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP2—epilepsy syndrome	4.34e-05	0.00036	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CHRM3—epilepsy syndrome	4.34e-05	0.00036	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GRM5—epilepsy syndrome	4.34e-05	0.00036	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CDC42—epilepsy syndrome	4.29e-05	0.000357	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GAL—epilepsy syndrome	4.29e-05	0.000357	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GFAP—epilepsy syndrome	4.29e-05	0.000357	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT3—epilepsy syndrome	4.27e-05	0.000355	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AVP—epilepsy syndrome	4.25e-05	0.000353	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CHRM3—epilepsy syndrome	4.25e-05	0.000353	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP2—epilepsy syndrome	4.25e-05	0.000353	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GRM5—epilepsy syndrome	4.25e-05	0.000353	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—UPB1—epilepsy syndrome	4.24e-05	0.000352	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ATIC—epilepsy syndrome	4.24e-05	0.000352	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NEU1—epilepsy syndrome	4.24e-05	0.000352	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CX3CR1—epilepsy syndrome	4.16e-05	0.000346	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AVP—epilepsy syndrome	4.16e-05	0.000345	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	4.09e-05	0.000339	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	4.08e-05	0.000339	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CX3CL1—epilepsy syndrome	4.08e-05	0.000339	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	4.08e-05	0.000339	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	4.07e-05	0.000338	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	3.99e-05	0.000331	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	3.99e-05	0.000331	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	3.99e-05	0.000331	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	3.99e-05	0.000331	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	3.97e-05	0.00033	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	3.95e-05	0.000328	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GBE1—epilepsy syndrome	3.95e-05	0.000328	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	3.9e-05	0.000324	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	3.88e-05	0.000322	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	3.86e-05	0.00032	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	3.81e-05	0.000316	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	3.77e-05	0.000314	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	3.75e-05	0.000311	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	3.72e-05	0.000309	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	3.71e-05	0.000308	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	3.66e-05	0.000304	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	3.61e-05	0.0003	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	3.61e-05	0.0003	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	3.54e-05	0.000294	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	3.54e-05	0.000294	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	3.53e-05	0.000294	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	3.52e-05	0.000292	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	3.52e-05	0.000292	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	3.46e-05	0.000287	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	3.46e-05	0.000287	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	3.45e-05	0.000286	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	3.45e-05	0.000286	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	3.37e-05	0.00028	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	3.37e-05	0.00028	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	3.36e-05	0.000279	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	3.35e-05	0.000279	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	3.35e-05	0.000279	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	3.33e-05	0.000276	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	3.33e-05	0.000276	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	3.33e-05	0.000276	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	3.33e-05	0.000276	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	3.33e-05	0.000276	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	3.28e-05	0.000273	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	3.28e-05	0.000273	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	3.28e-05	0.000273	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	3.25e-05	0.00027	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	3.25e-05	0.00027	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	3.25e-05	0.00027	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	3.25e-05	0.00027	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	3.25e-05	0.00027	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	3.22e-05	0.000267	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	3.21e-05	0.000267	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	3.21e-05	0.000267	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	3.15e-05	0.000262	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	3.14e-05	0.000261	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.1e-05	0.000257	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	3.1e-05	0.000257	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	3.09e-05	0.000257	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	3.09e-05	0.000257	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	3.05e-05	0.000253	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.03e-05	0.000252	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	3.02e-05	0.000251	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	3.02e-05	0.000251	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	3.01e-05	0.00025	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	3.01e-05	0.00025	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	3.01e-05	0.00025	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	2.98e-05	0.000248	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	2.98e-05	0.000248	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.94e-05	0.000244	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	2.94e-05	0.000244	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	2.94e-05	0.000244	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	2.94e-05	0.000244	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	2.93e-05	0.000243	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	2.92e-05	0.000242	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	2.9e-05	0.000241	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	2.88e-05	0.000239	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	2.87e-05	0.000238	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	2.83e-05	0.000235	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	2.83e-05	0.000235	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	2.82e-05	0.000235	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	2.82e-05	0.000234	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	2.81e-05	0.000233	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	2.8e-05	0.000233	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	2.78e-05	0.000231	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	2.78e-05	0.000231	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	2.77e-05	0.00023	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	2.77e-05	0.00023	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	2.77e-05	0.00023	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	2.76e-05	0.000229	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	2.75e-05	0.000229	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	2.74e-05	0.000228	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	2.72e-05	0.000226	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	2.72e-05	0.000226	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	2.71e-05	0.000225	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	2.71e-05	0.000225	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	2.65e-05	0.00022	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	2.63e-05	0.000218	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	2.58e-05	0.000214	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	2.57e-05	0.000214	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	2.56e-05	0.000213	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.54e-05	0.000211	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.54e-05	0.000211	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	2.52e-05	0.00021	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	2.52e-05	0.000209	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	2.51e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	2.51e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	2.47e-05	0.000205	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	2.45e-05	0.000204	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	2.38e-05	0.000198	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	2.36e-05	0.000196	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	2.35e-05	0.000196	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	2.33e-05	0.000194	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	2.31e-05	0.000192	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	2.3e-05	0.000191	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	2.28e-05	0.000189	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	2.23e-05	0.000185	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	2.16e-05	0.000179	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	2.11e-05	0.000175	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	2.1e-05	0.000174	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	2.09e-05	0.000173	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	2.08e-05	0.000173	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.07e-05	0.000172	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	2.05e-05	0.00017	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	2.04e-05	0.00017	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	2.04e-05	0.000169	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.02e-05	0.000168	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.02e-05	0.000167	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.01e-05	0.000167	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	1.99e-05	0.000165	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.97e-05	0.000164	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	1.95e-05	0.000162	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	1.94e-05	0.000161	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	1.9e-05	0.000158	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	1.9e-05	0.000157	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	1.86e-05	0.000154	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	1.8e-05	0.00015	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	1.8e-05	0.000149	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	1.76e-05	0.000146	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	1.76e-05	0.000146	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	1.76e-05	0.000146	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	1.73e-05	0.000143	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	1.73e-05	0.000143	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.72e-05	0.000143	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.72e-05	0.000143	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	1.69e-05	0.00014	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	1.66e-05	0.000138	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	1.66e-05	0.000138	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.64e-05	0.000136	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	1.63e-05	0.000135	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.62e-05	0.000135	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	1.62e-05	0.000135	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TH—epilepsy syndrome	1.61e-05	0.000134	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	1.51e-05	0.000126	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	1.48e-05	0.000123	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	1.48e-05	0.000123	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	1.45e-05	0.00012	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.35e-05	0.000112	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	1.34e-05	0.000111	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.33e-05	0.00011	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	1.31e-05	0.000109	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.29e-05	0.000107	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	1.24e-05	0.000103	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	1.22e-05	0.000101	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	1.22e-05	0.000101	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.2e-05	9.99e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	1.19e-05	9.91e-05	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.13e-05	9.4e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	1.12e-05	9.32e-05	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.11e-05	9.2e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	1.1e-05	9.11e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	1.09e-05	9.05e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	1.07e-05	8.85e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	1.06e-05	8.8e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.05e-05	8.76e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	1.04e-05	8.61e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.03e-05	8.58e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	1.03e-05	8.54e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	1.01e-05	8.35e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	9.77e-06	8.12e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	9.56e-06	7.94e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	9.52e-06	7.9e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	9.31e-06	7.73e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—POMC—epilepsy syndrome	8.88e-06	7.37e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALB—epilepsy syndrome	8.09e-06	6.72e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	7.08e-06	5.88e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	6.07e-06	5.04e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	5.94e-06	4.93e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.56e-06	2.95e-05	CbGpPWpGaD
